On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.

Check out the Les Echos article on our innovative Deeplex-MycTB solution, a next-generation test for combating multidrug-resistant TB.

GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.

Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.

pdfDownload the press release245.62 KB

Discover La Gazette Nord-Pas de Calais article about our company "GenoScreen dissects DNA"

pdfgazette-nord-pas-de-calais-janvier-2018.pdf206.33 KB18.pdf

On the 4th and 5th of December 2018, GenoScreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.

Join the GenoScreen team, we are looking for a Technical Sales Engineer, Genomics Specialty, apply!

GenoScreen will present the conclusions of the BioDISSPOL project on November 28 at Pollutec Lyon during the panel discussion: "Microbial Biomarkers : Application to the diagnosis and management of polluted sites".

By continuing your visit to this site, you accept the use of statistics cookies